Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Minimally-Invasive, High-Resolution Restoration of Vision Using Photothermal Activation of Retinal Neurons
Author Affiliations & Notes
  • Jiarui Nie
    Institute for Biology, Engineering and Medicine, Brown University, Providence, Rhode Island, United States
    Carney Institute for Brain Science, Brown University, Providence, Rhode Island, United States
  • Kyungsik Eom
    Department of Electronics Engineering, Pusan National University, Kumjeong-ku, Korea (the Republic of)
  • Hafithe Alghosain
    Institute for Biology, Engineering and Medicine, Brown University, Providence, Rhode Island, United States
  • Jonghwan Lee
    Institute for Biology, Engineering and Medicine, Brown University, Providence, Rhode Island, United States
    Carney Institute for Brain Science, Brown University, Providence, Rhode Island, United States
  • Footnotes
    Commercial Relationships   Jiarui Nie None; Kyungsik Eom None; Hafithe Alghosain None; Jonghwan Lee None
  • Footnotes
    Support  NEI Grant R01EY030569
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1489. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jiarui Nie, Kyungsik Eom, Hafithe Alghosain, Jonghwan Lee; Minimally-Invasive, High-Resolution Restoration of Vision Using Photothermal Activation of Retinal Neurons. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1489.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinal prosthesis aims to restore vision by implanting electronic hardware in irreversible photoreceptor degeneration diseases. The limitations of current clinical devices are that the visual acuity is still worse than legal blindness and requires complex implant surgery. To break the limitations, we utilized intravitreal injectable retinal ganglion cells (RGCs)-binding gold nanorods (AuNRs) as miniature near-infrared (NIR) laser enhancers to photothermally activate RGCs and thereby restore vision with negligible side effects.

Methods : By intravitreally injecting Thy-1 antibody-conjugated gold nanorods (AuNRs) in mice and stimulating RGCs with a square pattern of NIR laser beams (980 nm wavelength), we recorded neural activities of RGCs on live retinal explants of GCaMP3 mice via fluorescence Ca2+ imaging. We examined how AuNRs-enhanced NIR stimulation interfaces with RGCs on temperature-sensitive ion channels via applying multiple transient receptor potential vanilloid (TRPV) blockers. To validate the efficacy in vivo, we recorded electrocorticograms from the visual cortex of mice injected with either AuNRs or PBS while illuminating the square pattern of NIR laser on the retina.

Results : Compared to PBS-injected retinas (n = 4), NIR laser projection evoked increases in the Ca2+ fluorescence of the AuNRs injected retinal neurons in a laser intensity-dependent manner, up to 5 % △F/F (n = 9). The change of fluorescence for all the responsive RGCs was highly localized inside the 100 μm-width square pattern of the NIR laser-illuminated area, indicating a spatial resolution of 100 μm. RGCs responses were blocked by TRPV1 antagonist rather than TRPV4 antagonist, suggesting this photothermal approach transiently opened TRPV1 channel on the neural membrane to activate RGCs via surface plasmon resonance. For in vivo, with the 160-μm (3 degrees field-of-view) square pattern of NIR laser projection, AuNRs injected mice (n = 6) elicited significant evoked potentials on the visual cortex in a laser intensity-dependent manner, but PBS-injected mice (n = 4) did not respond to NIR light.

Conclusions : Our study provides the promising potential for the development of a novel generation of a minimally-invasive, high-resolution photothermal retinal prosthetic device without genetic manipulation to restore vision in blindness.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×